Boston, MA
2012-06-6
Regulatory agencies’ changing focus and expanding expectations regarding GCP compliance will be addressed at the Second Annual Clinical Auditing Forum. Attendees can expect presentations on auditing best practices, strategies, and techniques to ensure that solid GCP compliance and scientific and ethical standards are maintained throughout the conduct of clinical trials. Sessions will be focused on developing and strengthening auditing programs, implementing proven techniques for audit planning, and ultimately ensuring clinical research compliance through strategic approaches to clinical quality assurance. FDA and international regulatory agency expectations and recent inspection trends will be discussed. Speakers will present real-world examples of risk-based approaches to auditing sites, systems, and providers.
|
|